Swisher Financial Concepts’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.2M Sell
44,678
-7,211
-14% -$1.55M 7.08% 4
2026
Q1
$11.3M Buy
51,889
+23
+0% +$5.1K 6.31% 4
2025
Q4
$11.9M Sell
51,866
-29
-0.1% -$6.61K 6.73% 3
2025
Q3
$12M Sell
51,895
-198
-0.4% -$40.3K 7.2% 3
2025
Q2
$9.67M Sell
52,093
-121
-0.2% -$22.5K 6.24% 4
2025
Q1
$10.9M Buy
52,214
+130
+0.2% +$25.3K 9.04% 2
2024
Q4
$9.26M Sell
52,084
-23
-0% -$4.23K 10.9% 1
2024
Q3
$10.2M Buy
52,107
+2
+0% +$373 6.43% 4
2024
Q2
$8.65M Sell
52,105
-48
-0.1% -$7.95K 8.76% 2
2024
Q1
$8.78M Buy
52,153
+23
+0% +$3.96K 7.64% 2
2023
Q4
$8.43M Buy
+52,130
New +$7.6M 8.12% 1

Other funds holding ABBV

Swisher Financial Concepts's ABBV Position: Q2 2026 in Review

Swisher Financial Concepts reduced its AbbVie (ABBV) stake by 14% in Q2 2026, selling an estimated $1.55M and leaving 44,678 shares worth $11.2M. The position accounts for 7.08% of the portfolio, ranked #4.

Swisher Financial Concepts first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $12M in Q3 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Swisher Financial Concepts held 44,678 shares of AbbVie worth $11.2M as of Q2 2026.
  • Swisher Financial Concepts sold 7,211 AbbVie shares in Q2 2026, an estimated $1.55M.
  • AbbVie made up 7.08% of Swisher Financial Concepts's portfolio in Q2 2026, its #4 holding.
  • Swisher Financial Concepts first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • Swisher Financial Concepts's AbbVie position peaked at $12M in Q3 2025.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Swisher Financial Concepts's 13F filing for Q2 2026, filed 6 Aug 2026.